News tagged with journal of clinical oncology

New brain cancer treatment may be more effective, less toxic

(Medical Xpress)—A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to ...

Cancer created Apr 09, 2013 | popularity not rated yet | comments 0 | with audio podcast

Researchers discover new pathways that drive metastatic prostate cancer

Elevated levels of Cyclin D1b could function as a novel biomarker of lethal metastatic disease in prostate cancer patients, according to a pre-clinical study published ahead of print on December 21 in the Journal of Clinical In ...

Cancer created Dec 21, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Older and younger chronic leukemia patients may need different therapy

Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur ...

Cancer created Dec 12, 2012 | popularity not rated yet | comments 0 | with audio podcast

Delaying treatment for advanced breast cancer more than 60 days has 'profound effect', researchers find

(Medical Xpress)—Results from a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) show ...

Cancer created Nov 22, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Pathway identified in human lymphoma points way to new blood cancer treatments

A pathway called the "Unfolded Protein Response," or UPR, a cell's way of responding to unfolded and misfolded proteins, helps tumor cells escape programmed cell death during the development of lymphoma.

Cancer created Nov 21, 2012 | popularity not rated yet | comments 0 | with audio podcast

Ovarian cancer patients have lower mortality rates when treated at high-volume hospitals

A study by researchers at the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia University Medical Center, recently e-published ahead of print by the Journal of Clinical Oncology, sugges ...

Cancer created Nov 08, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Older breast cancer patients see more complications with brachytherapy

heralded for its low complication rates—actually results in more complications than whole-breast radiation one year after treatment, Yale School of Medicine researchers report in the October issue of the Journal of Clinical On ...

Cancer created Oct 22, 2012 | popularity not rated yet | comments 0 | with audio podcast

Review finds some evidence for 'chemo brain' in breast cancer survivors

(Medical Xpress)—A large meta-analysis conducted by researchers at Moffitt Cancer Center has concluded that breast cancer patients treated with chemotherapy are at risk for mild cognitive deficits after treatment. The meta-analysis, ...

Cancer created Sep 04, 2012 | popularity not rated yet | comments 0 | with audio podcast

Study pinpoints malignant mesothelioma patients likely to benefit from drug pemetrexed

Previous studies have hypothesized that low levels of the enzyme thymidylate synthase (TS) likely mark patients who will benefit from the drug pemetrexed – but results have been inconclusive at best and at times contradictory. ...

Cancer created Aug 29, 2012 | popularity not rated yet | comments 0 | with audio podcast

Daily aspirin may help fight prostate cancer, but not breast cancer

(HealthDay)—Two new studies paint a complex portrait of aspirin's impact on cancer risk and mortality, with one suggesting the drug may lower the risk of dying from prostate cancer and the other seeing ...

Cancer created Aug 27, 2012 | popularity not rated yet | comments 0 | with audio podcast

Metastatic melanoma responds to first-line interleukin-21

(HealthDay)—In the first-line treatment of metastatic melanoma, interleukin-21 (IL-21) shows an overall response rate (ORR) of 22.5 percent and warrants further study, according to research published online ...

Cancer created Aug 23, 2012 | popularity not rated yet | comments 0 | with audio podcast

HPV test beats pap long-term: study

(HealthDay) -- Testing for HPV, the human papillomavirus linked to cervical cancer, can predict which women will stay cancer-free for a decade or more, a new study shows.

Cancer created Jul 30, 2012 | popularity not rated yet | comments 0 | with audio podcast

Benefits of prostate-specific antigen testing remain unclear

(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, ...

Cancer created Jul 20, 2012 | popularity not rated yet | comments 3 | with audio podcast

Cardio fitness levels of breast cancer patients may affect survival

Women receiving care for breast cancer have significantly impaired cardio-pulmonary function that can persist for years after they have completed treatment, according to a study led by scientists at Duke University Medical ...

Cancer created May 23, 2012 | popularity not rated yet | comments 0 | with audio podcast

Lung cancer CT scans: Just for older heavy smokers

New lung cancer screening guidelines from three medical groups recommend annual scans but only for an older group of current or former heavy smokers.

Cancer created May 20, 2012 | popularity 5 / 5 (1) | comments 0

Journal of Clinical Oncology

The Journal of Clinical Oncology (JCO) is a medical journal published by the American Society of Clinical Oncology (ASCO). The Journal was founded in 1983 and publishes original research and review articles on topics relating to cancer. It is published 3 times a month. The Journal's impact factor in 2007 was 15.484, making it one of the highest-impact journals in the field of oncology.

For more information about Journal of Clinical Oncology, read the full article at Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.